Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease

author
created [InstanceEdit:9845157] Stephan, Ralf, 2023-09-27
dbId 9845089
displayName Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
journal Drug Healthc Patient Saf
pages 103-112
pubMedIdentifier 37720805
schemaClass LiteratureReference
title Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
url http://www.ncbi.nlm.nih.gov/pubmed/37720805
volume 15
year 2023
Cite Us!